LKFT
As of 2026-11-06, Lakefront Biotherapeutics NV (LKFT) has a market capitalization of $2.21 B, making it the #2011 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $2.21 B |
| 2026-11-05 | $2.21 B |
| 2026-11-04 | $2.25 B |
| 2026-11-03 | $2.12 B |
| 2026-11-02 | $2.11 B |
| 2026-11-01 | $2.13 B |
| 2026-10-31 | $2.13 B |
| 2026-10-30 | $2.14 B |
| 2026-10-29 | $2.13 B |
| 2026-10-28 | $2.11 B |
| 2026-10-27 | $2.09 B |
| 2026-10-26 | $2.09 B |
As of 2026-11-06, Lakefront Biotherapeutics NV (LKFT) has a market capitalization of $2.21 B, making it the #2011 most valuable US-listed company.
Lakefront Biotherapeutics NV is the #2011 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $2.09 B |
| 2026-10-24 | $2.09 B |
| 2026-10-23 | $2.09 B |
| 2026-10-22 | $2.07 B |
| 2026-10-21 | $2.02 B |
| 2026-10-20 | $2.03 B |
| 2026-10-19 | $1.96 B |
| 2026-10-18 | $1.97 B |
| 2026-10-17 | $1.97 B |
| 2026-10-16 | $1.97 B |
| 2026-10-15 | $1.98 B |
| 2026-10-14 | $1.93 B |
| 2026-10-13 | $1.91 B |
| 2026-10-12 | $1.95 B |
| 2026-10-11 | $1.96 B |
| 2026-10-10 | $1.96 B |
| 2026-10-09 | $1.95 B |
| 2026-10-08 | $1.94 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.